[HTML][HTML] Systemic immune-inflammation index and circulating T-cell immune index predict outcomes in high-risk acral melanoma patients treated with high-dose …
J Yu, X Wu, H Yu, S Li, LL Mao, Z Chi, L Si… - Translational …, 2017 - Elsevier
High-dose interferon alfa-2b (IFN-α-2b) improves the survival of patients with high-risk
melanoma. We aimed to identify baseline peripheral blood biomarkers to predict the …
melanoma. We aimed to identify baseline peripheral blood biomarkers to predict the …
Systemic Immune-Inflammation Index and Circulating T-Cell Immune Index Predict Outcomes in High-Risk Acral Melanoma Patients Treated with High-Dose Interferon
J Yu, X Wu, H Yu, S Li, LL Mao, Z Chi… - Translational …, 2017 - pubmed.ncbi.nlm.nih.gov
High-dose interferon alfa-2b (IFN-α-2b) improves the survival of patients with high-risk
melanoma. We aimed to identify baseline peripheral blood biomarkers to predict the …
melanoma. We aimed to identify baseline peripheral blood biomarkers to predict the …
[HTML][HTML] Systemic Immune-Inflammation Index and Circulating T-Cell Immune Index Predict Outcomes in High-Risk Acral Melanoma Patients Treated with High-Dose …
J Yu, X Wu, H Yu, S Li, LL Mao, Z Chi, L Si… - Translational …, 2017 - ncbi.nlm.nih.gov
High-dose interferon alfa-2b (IFN-α-2b) improves the survival of patients with high-risk
melanoma. We aimed to identify baseline peripheral blood biomarkers to predict the …
melanoma. We aimed to identify baseline peripheral blood biomarkers to predict the …
Systemic Immune-Inflammation Index and Circulating T-Cell Immune Index Predict Outcomes in High-Risk Acral Melanoma Patients Treated with High-Dose Interferon …
J Yu, X Wu, H Yu, S Li, L Mao, Z Chi, L Si… - Translational …, 2017 - europepmc.org
High-dose interferon alfa-2b (IFN-α-2b) improves the survival of patients with high-risk
melanoma. We aimed to identify baseline peripheral blood biomarkers to predict the …
melanoma. We aimed to identify baseline peripheral blood biomarkers to predict the …
Systemic Immune-Inflammation Index and Circulating T-Cell Immune Index Predict Outcomes in High-Risk Acral Melanoma Patients Treated with High-Dose Interferon …
J Yu, X Wu, H Yu, S Li, L Mao, Z Chi, L Si… - Translational …, 2017 - europepmc.org
High-dose interferon alfa-2b (IFN-α-2b) improves the survival of patients with high-risk
melanoma. We aimed to identify baseline peripheral blood biomarkers to predict the …
melanoma. We aimed to identify baseline peripheral blood biomarkers to predict the …